An immunohistochemical analysis of 119 human ovarian cancer samples showed that the expression of CDK1 is a prognostic factor in epithelial ovarian cancer, and knockdown of CDK1 promoted apoptosis and increased the sensitivity of epithelial ovarian cancer to chemotherapy drugs (Xi et al. 2015). This evidence concerns the gene CDK1 and ovarian carcinoma.